Company Analysis Артген биотех (ИСКЧ)
1. Summary
Advantages
- The stock's return over the last year (8.73%) is higher than the sector average (-9.32%).
Disadvantages
- Price (75.44 ₽) is higher than fair price (7.92 ₽)
- Dividends (0%) are below the sector average (9.17%).
- Current debt level 25.19% has increased over 5 years from 18.01%.
- The company's current efficiency (ROE=23.55%) is lower than the sector average (ROE=133.9%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Артген биотех (ИСКЧ) | Потреб | Index | |
|---|---|---|---|
| 7 days | -1.5% | 1% | 0.7% |
| 90 days | -10.9% | -13.1% | -14.8% |
| 1 year | 8.7% | -9.3% | -11.9% |
ABIO vs Sector: Артген биотех (ИСКЧ) has outperformed the "Потреб" sector by 18.05% over the past year.
ABIO vs Market: Артген биотех (ИСКЧ) has outperformed the market by 20.66% over the past year.
Stable price: ABIO is not significantly more volatile than the rest of the market on "Московская биржа" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ABIO with weekly volatility of 0.168% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (75.44 ₽) is higher than the fair price (7.92 ₽).
Price is higher than fair: The current price (75.44 ₽) is 89.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (30.65) is higher than that of the sector as a whole (8.57).
P/E vs Market: The company's P/E (30.65) is higher than that of the market as a whole (8.93).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (6.88) is lower than that of the sector as a whole (30.03).
P/BV vs Market: The company's P/BV (6.88) is higher than that of the market as a whole (1.36).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (4.86) is higher than that of the sector as a whole (1.19).
P/S vs Market: The company's P/S indicator (4.86) is higher than that of the market as a whole (1.15).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (41.48) is higher than that of the sector as a whole (4.31).
EV/Ebitda vs Market: The company's EV/Ebitda (41.48) is higher than that of the market as a whole (-2.38).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 46.07% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (46.07%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.14%).
5.4. ROE
ROE vs Sector: The company's ROE (23.55%) is lower than that of the sector as a whole (133.9%).
ROE vs Market: The company's ROE (23.55%) is higher than that of the market as a whole (13.17%).
5.5. ROA
ROA vs Sector: The company's ROA (9.25%) is lower than that of the sector as a whole (14.65%).
ROA vs Market: The company's ROA (9.25%) is higher than that of the market as a whole (7.28%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.55%) is lower than that of the sector as a whole (14.31%).
ROIC vs Market: The company's ROIC (7.55%) is lower than that of the market as a whole (16.32%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '9.17%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.43.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (58.34%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
9. Stocks forum Артген биотех (ИСКЧ)
9.1. Stocks forum - Latest comments
9.2. Latest Blogs
Факторы способные замедлить падение рынка. К чему готовиться инвестору
Российский фондовый рынок остается под давлением. Снижение, начатое в пятницу, продолжается. По итогам дневных торгов индекс МосБиржи потерял 0,56% и составил 2722,37 п., индекс РТС подрос на 0,14% 1- до 1091,1 п....
More
⚡ИНТЕРЕСНЫЙ РАСКЛАД ⚡ #новости
12.05.2025
🇷🇺 Итак, индекс расцвёл зелёным цветом, показывая рост почти на 3%. Этому способствовали позитивные ожидания по сделанным геополитическим заявлениям. И хотя к вечеру рост сбавил темп, выскочил Трамп, как джокер из колоды, и заявил, что может в четверг поехать в Стамбул. Добавив, что результаты могут быть положительными....
More
📈 МосБиржа закрепилась над 3000
Пятница завершилась для российского рынка на мажорной ноте: Индекс МосБиржи прибавил почти 2,5%, уверенно пробив психологическую отметку в 3000 пунктов. #MOEX
И это было только начало: в рабочие выходные акции продолжили раллировать — в субботу по ряду бумаг даже сработали верхние планки роста....
More
All blogs ⇨
